Core-008
核心008
基本信息
- 批准号:10414775
- 负责人:
- 金额:$ 33.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-05-01 至 2023-11-15
- 项目状态:已结题
- 来源:
- 关键词:AwardCapital FinancingClinicalClinical SciencesCollaborationsColoradoCourse ContentDevelopmentEconomic DevelopmentEcosystemEducationEntrepreneurshipFacultyFosteringFundingGoalsHealthInfrastructureInnovation CorpsInstitutesInternationalInvestmentsLeadMentorshipNational Center for Advancing Translational SciencesProcessResourcesRewardsScienceServicesTrainers TrainingTrainingTraining ProgramsTranslational ResearchTranslationsUnited States National Institutes of HealthUniversitiescareercommercializationexperiencegraduate studentinnovationproduct developmentprogramstraining opportunity
项目摘要
The Innovation Ecosystem (Partnering for Innovation Value Optimization and Accelerated Translation
[PIVOT]) program will embrace innovation and commercial translation to advance biomedical discoveries into
the marketplace. Through this Optional Function of the CCTSI, we will develop and sustain an innovation
program to educate, train and develop our workforce in commercial value translation; to support the technical
development of commercializable innovation; and to demonstrate value and health impact of clinical and
translational science innovation by providing access to accelerator venture capital funding, domain expertise,
and commercialization mentorship. The overall goal of PIVOT is to provide a seamless, multi-level investigatorfacing
infrastructure supporting the commercialization and product development of innovative ideas and, in the
process, support and academically reward entrepreneurship. We will achieve these goals through the following
specific aims: Aim 1: Workforce. Catalyze an academic entrepreneur culture and workforce by (a) disseminating
and expanding the reach of bio-entrepreneurship training opportunities, (b) fostering entrepreneurial networking,
and (c) demonstrating career trajectories for faculty and graduate students who are clinical and translational
science innovators. Aim 2: Development. Accelerate the development of commercializable innovation through
customer discovery by Innovation-Corps (I-Corps™) teams and promote combined usage of I-Corps and Team
Science training for innovation teams receiving CCTSI pilot awards. Aim 3: Demonstrate impact. Accelerate
health impact demonstration through active navigation to resources within the CCTSI ecosystem which provide
commercialization mentorship, domain expertise, and accelerator funding. The CCTSI PIVOT program will serve
as an integrator-navigator and resource multiplier to expand and extend the reach of entrepreneurial investment
and infrastructure support provided by University of Colorado and Colorado State University and the Colorado
Office of Economic Development and International Trade. PIVOT will also capitalize on two unique NIH workforce
training programs in Colorado: the Broadening Experiences in Scientific Training (BEST) award for graduate
trainees in clinical and translational sciences; and the I-Corps™ Train-the-Trainer program at NCATS to develop
a scalable short-course curriculum and common metrics adapted to the needs of clinical and translational
science programs that will be disseminated across the CTSA consortium. In collaboration with an extensive
network of state-wide, national and institutional innovation and entrepreneurship partnerships, PIVOT will lead a
major academic shift within the CCTSI ecosystem by embracing innovation and commercial translation to
advance biomedical discoveries into the marketplace. We will foster a culture that supports startup incubation
and provides education and practical training to help academic ventures develop commercially-viable products
and services.
创新生态系统(创新价值优化与加速转化的伙伴关系)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RONALD J. SOKOL其他文献
RONALD J. SOKOL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RONALD J. SOKOL', 18)}}的其他基金
Colorado Clinical and Transational Sciences Institute
科罗拉多临床和转化科学研究所
- 批准号:
9926512 - 财政年份:2019
- 资助金额:
$ 33.52万 - 项目类别:
Colorado Clinical and Transational Sciences Institute
科罗拉多临床和转化科学研究所
- 批准号:
9926131 - 财政年份:2018
- 资助金额:
$ 33.52万 - 项目类别:
Colorado Clinical and Translational Sciences Institute: UL1 Diversity KL2 Supplement
科罗拉多临床和转化科学研究所:UL1 多样性 KL2 补充材料
- 批准号:
10288971 - 财政年份:2018
- 资助金额:
$ 33.52万 - 项目类别:
Colorado Clinical and Transational Sciences Institute
科罗拉多临床和转化科学研究所
- 批准号:
10402976 - 财政年份:2018
- 资助金额:
$ 33.52万 - 项目类别:
相似海外基金
Venture Capital Financing and Methods of Payment in Mergers and Acquisitions.
并购中的风险投资融资和支付方式。
- 批准号:
20K13530 - 财政年份:2020
- 资助金额:
$ 33.52万 - 项目类别:
Grant-in-Aid for Early-Career Scientists














{{item.name}}会员




